Company Kane Biotech Inc Toronto S.E.
Equities
KNE
CA4838092084
Biotechnology & Medical Research
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
All Other
100.0
%
| 0 | 5.9 % | 0 | 100.0 % | -4.95% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
International
93.1
%
| 1 | 55.5 % | 0 | 93.1 % | -90.63% |
Canada
6.9
%
| 1 | 44.5 % | 0 | 6.9 % | -99.13% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marc Edwards
CEO | Chief Executive Officer | - | 01/06/16 |
Ray Dupuis
DFI | Director of Finance/CFO | - | 04/09/17 |
Compliance Officer | - | 11/08/19 | |
Gregory Schultz
CTO | Chief Tech/Sci/R&D Officer | 73 | 04/04/22 |
John Coleman
BRD | Director/Board Member | - | 11-15 |
Wendy Nachtigall
SAM | Sales & Marketing | - | 30/09/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
R. Renaud
BRD | Director/Board Member | - | 14/09/10 |
Chairman | 59 | 02-19 | |
Georges Morin
BRD | Director/Board Member | - | 19/05/20 |
Marc Edwards
CEO | Chief Executive Officer | - | 01/06/16 |
John Coleman
BRD | Director/Board Member | - | 11-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 131,844,567 | 85,786,381 ( 65.07 %) | 0 | 65.07 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+27.41% | 44.96B | |
+0.10% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.23% | 26.08B | |
-21.10% | 19.03B | |
+6.35% | 12.75B | |
+28.79% | 12.06B | |
-4.12% | 11.75B |